ADAR1 Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.19M Sell
2025
Q2
$2.38M Buy
2025
Q1
$1.06M Buy
2024
Q4
$498K Buy
2024
Q3
$209K Buy
2024
Q2
$104K Buy
2024
Q1
$44.6K Buy